Home
/
Aspira Women's Health Inc.
/
Financials
/
Quarterly
Aspira Women's Health Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Aspira Women's Health Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$89.0K
Nov 14, 2025
Q2
2025
Jun 30, 2025
$169.0K
Aug 13, 2025
Q3
2023
Sep 30, 2023
$2.22M
Nov 13, 2023
Q2
2023
Jun 30, 2023
$2.49M
Aug 14, 2023
Q1
2023
Mar 31, 2023
$2.32M
May 15, 2023
Q3
2023
Sep 30, 2022
$2.07M
Nov 13, 2023
Q2
2023
Jun 30, 2022
$2.07M
Aug 14, 2023
Q1
2023
Mar 31, 2022
$1.89M
May 15, 2023
Q3
2022
Sep 30, 2021
$1.67M
Nov 10, 2022
Q2
2022
Jun 30, 2021
$1.80M
Aug 10, 2022
Q1
2022
Mar 31, 2021
$1.50M
May 11, 2022
Q3
2021
Sep 30, 2020
$1.24M
Nov 10, 2021
Q2
2021
Jun 30, 2020
$746.0K
Aug 12, 2021
Q1
2021
Mar 31, 2020
$1.22M
May 14, 2021
Q3
2020
Sep 30, 2019
$1.29M
Nov 12, 2020
Q2
2020
Jun 30, 2019
$1.14M
Aug 14, 2020
Q1
2020
Mar 31, 2019
$803.0K
May 14, 2020
Q3
2019
Sep 30, 2018
$774.0K
Nov 12, 2019
Q2
2019
Jun 30, 2018
$708.0K
Aug 8, 2019
Q1
2019
Mar 31, 2018
$649.0K
May 14, 2019
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$2.31M
Nov 14, 2025
Q2
2025
Jun 30, 2025
$2.40M
Aug 13, 2025
Q1
2025
Mar 31, 2025
$2.28M
May 19, 2025
Q3
2025
Sep 30, 2024
$2.26M
Nov 14, 2025
Q2
2025
Jun 30, 2024
$2.42M
Aug 13, 2025
Q1
2025
Mar 31, 2024
$2.15M
May 19, 2025
Q3
2024
Sep 30, 2023
$2.22M
Nov 19, 2024
Q2
2024
Jun 30, 2023
$2.49M
Aug 13, 2024
Q1
2024
Mar 31, 2023
$2.32M
May 15, 2024
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($4.89M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($2.67M)
Aug 13, 2025
Q3
2025
Jun 30, 2025
($2.67M)
Nov 14, 2025
Q3
2025
Mar 31, 2025
($1.85M)
Nov 14, 2025
Q2
2025
Mar 31, 2025
($1.85M)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($1.85M)
May 19, 2025
Q3
2025
Sep 30, 2024
($3.55M)
Nov 14, 2025
Q3
2025
Jun 30, 2024
($3.53M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($3.53M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($4.63M)
May 19, 2025
Q3
2025
Mar 31, 2024
($4.63M)
Nov 14, 2025
Q2
2025
Mar 31, 2024
($4.63M)
Aug 13, 2025
Q3
2024
Sep 30, 2023
($4.71M)
Nov 19, 2024
Q2
2024
Jun 30, 2023
($2.32M)
Aug 13, 2024
Q3
2024
Jun 30, 2023
($2.32M)
Nov 19, 2024
Q2
2024
Mar 31, 2023
($6.58M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($6.58M)
May 15, 2024
Q3
2024
Mar 31, 2023
($6.58M)
Nov 19, 2024
Q3
2023
Sep 30, 2022
($7.78M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($8.24M)
Aug 14, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.58M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($1.81M)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($3.24M)
May 19, 2025
Q3
2025
Sep 30, 2024
($3.74M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($4.39M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($4.71M)
May 19, 2025
Q3
2024
Sep 30, 2023
($4.12M)
Nov 19, 2024
Q2
2024
Jun 30, 2023
($4.32M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($6.28M)
May 15, 2024
Q3
2023
Sep 30, 2022
($8.58M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($8.22M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($9.25M)
May 15, 2023
Q3
2022
Sep 30, 2021
($9.69M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($8.07M)
Aug 10, 2022
Q1
2022
Mar 31, 2021
($5.89M)
May 11, 2022
Q3
2021
Sep 30, 2020
($4.28M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($3.83M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($3.80M)
May 14, 2021
Q3
2020
Sep 30, 2019
($3.85M)
Nov 12, 2020
Q2
2020
Jun 30, 2019
($4.31M)
Aug 14, 2020